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introduction: Although recently published guidelines recommend against the use of 
synthetic non-absorbable materials in cases of potentially contaminated or contaminated 
surgical fields due to the increased risk of infection (1, 2), the use of bio-prosthetic meshes 
for abdominal wall or ventral hernia repair is still controversially discussed in such cases. 
Bio-prosthetic meshes have been recommended due to less susceptibility for infection 
and the decreased risk of subsequent mesh explantation. The purpose of this review is 
to elucidate if there are any indications for the use of biological and biosynthetic meshes 
in incarcerated abdominal wall hernias based on the recently published literature.
Methods: A literature search of the Medline database using the PubMed search engine, 
using the keywords returned 486 articles up to June 2015. The full text of 486 articles 
was assessed and 13 relevant papers were identified including 5 retrospective case 
cohort studies, 2 case-controlled studies, and 6 case series.
Results: The results of Franklin et al. (3–5) included the highest number of biological 
mesh repairs (Surgisis®) by laparoscopic IPOM in infected fields, which demonstrated 
a very low incidence of infection and recurrence (0.7 and 5.2%). Han et al. (6) reported 
in his retrospective study, the highest number of treated patients due to incarcerated 
hernias by open approach using acellular dermal matrix (ADM®) with very low rate of 
infection as well as recurrences (1.6 and 15.9%). Both studies achieved acceptable 
outcome in a follow-up of at least 3.5 years compared to the use of synthetic mesh in 
this high-risk population (7).
Conclusion: Currently, there is a very limited evidence for the use of biological and 
biosynthetic meshes in strangulated hernias in either open or laparo-endoscopic repair. 
Finally, there is an urgent need to start with randomized controlled comparative trials as 
well as to support registries with data to achieve more knowledge for tailored indication 
for the use of biological meshes.
Keywords: incarceration, strangulation, groin hernia surgery, abdominal wall hernia, biological mesh, incisional 
hernia, ventral hernia, bio-resorbable mesh
TABLe 1 | Summary of study demographics and characteristics.
Reference Study design COi Patient (n) Mean age Mean BMi FU Loe
Quartey et al. (16) CR NR 1 71 NR 5 months 4
Ueno et al. (15) CCS NR 20 60.1 NR 15.7 months 4
Xourafas et al. (12) RCS NR 51 59 29 > 30 22 months 3
Helton et al. (13) RCS NR 53 51 32 14 months 4
Giakoustidis et al. (17) CR No 1 53 NR 12 months 4
Shah et al. (9) RCS NR 58 57.2 33.8 12 months 4
Tsuda (22) CR No 1 33 38 6 weeks 4
Franklin et al. (5) CCS NR 116 58 NR 52 months 4
Han et al. (6) RCS No 63 57 29 43 months 4
Patton et al. (14) RCS NR 67 55 NR 10.6 months 4
Fallis et al. (18) CR NR 1 81 NR 6 months 4
Gooch et al. (19) CR No 1 38 NR 4 years 4
Pulido et al. (20) CR NR 1 70 NR NR 4
Schiergens et al. (21) CR NR 1 32 NR NR 4
n, number; RCS, Retrospective Cohort Study; CCS, Case–Control Study; CR, case report; COI, conflict of interest; NR, no report; LoE, level of evidence (based on the Oxford 
Centre for Levels of Evidence 2009).
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iNTRODUCTiON
The BioMesh Study Group has set itself the task of identifying the 
best way to use biological meshes for various indications. The first 
step (toward achieving that goal) is to compile systematic reviews 
of different indications on the basis of the existing literature. 
The available literature sources will be evaluated in accordance 
with the Oxford Centre for Evidence-based Medicine-Levels of 
Evidence (March 2009). Next, based on the review findings, cor-
responding Statements and Recommendations are to be formu-
lated in a Consensus Conference for the use of biological meshes 
regarding different indications. The findings of the Consensus 
Conference will then be summarized as a joint publication. 
This present publication is part of the project undertaken by the 
BioMesh Study Group.
Although recently published guidelines recommend against 
the use of synthetic non-absorbable materials in cases of 
potentially contaminated or contaminated surgical fields due to 
the increased risk of infection (1, 2), the use of bio-prosthetic 
meshes for abdominal wall or ventral hernia repair is still con-
troversially discussed in such cases. Especially in these indica-
tions, bio- prosthetic meshes have been recommended due to less 
susceptibility for infection and the decreased risk of subsequent 
mesh explantation. The greatest drawback of bio-prosthetics is still 
the high cost in comparison to synthetic non-absorbable meshes 
(2). Above all, there is a lack of evidence concerning the clinical 
efficacy of biologic over synthetic non-absorbable meshes (7). In 
the literature, wound infection rates after the use of biological 
meshes even in clean-contaminated fields are reported up to 40% 
(8, 9) and hernia recurrence rates up to 30%, respectively (10). 
On the other hand, the reports of Zafar et al. (11) regarding emer-
gency surgery of incarcerated incisional hernia with associated 
bowel obstructions enrolling 60 patients by the use of permanent 
prosthetic meshes revealed an almost identically high percent-
age (31%) of wound complications in a retrospective study. The 
purpose of this review is to elucidate if there are any indications 
for the use of biological and biosynthetic meshes in incarcerated 
abdominal wall hernias based on the recently published literature.
MeTHODS
A literature search of the Medline database using the PubMed 
search engine, using the keywords (incarcerated hernia OR 
strangulated hernia OR inguinal hernia OR Groin hernia OR 
inguinal hernia OR ventral hernia OR incisional hernia AND 
biological mesh OR Biomesh OR Biological OR biosynthetic 
mesh AND open repair OR laparoscopic repair OR endoscopic 
repair) returned 486 articles up to June 2015. Titles and abstracts 
were searched for the use of biologic meshes in open and laparo-
endoscopic repair of incarcerated/strangulated abdominal wall 
hernias. The full text of 486 articles was assessed, and 13 relevant 
papers were identified including 5 retrospective case cohort stud-
ies (9, 12–14), 2 case-controlled studies (5, 15) and 6 case reports 
(16–21). A summary of study demographics and characteristics is 
presented in Table 1 and the outcome data in Table 2. Qualitative 
assessment of all included studies was based on the Oxford Centre 
for Evidence-Based Medicine 2009 levels of evidence.
ReSULTS
In the special case of an incarcerated recurrent Amyand’s 
hernia, the only paper concerning the use of a biological mesh 
was published by Quartey et  al. (16). After appendectomy in 
an open approach, an acellular hydrated dermis (Flex HD®) 
was implanted with an uneventful postoperative follow-up to 
5  months. In a review regarding Amyand’s hernia, Michalinos 
et al. (23) concluded that in case of proper treatment, including 
the use of meshes, the morbidity or mortality is not increased 
beyond that of a typical inguinal hernia repair. Similar conclu-
sions can be found in the review of Köckerling et al. (24) with the 
statement: “The use of biological meshes in inguinal hernia repair 
especially in potentially contaminated fields is an alternative to 
the use of synthetic meshes with reasonable recurrence rates.”
In the case cohort study of Ueno et  al. (15) including 2 
inguinal and 18 ventral hernias – 3 with incarceration – patients 
were treated with Surgisis® mesh implants. In a follow-up of 
15.7 months, no infection or recurrence was detected.
TABLe 2 | Outcome data.
Reference Mesh 
(n)
Meshtype Meshposition Fixation Hernia type (n) incarceration/
strangulation
Resection 
(bowel)
Recurrence 
(%)
wound 
infection (%)
Quartey  
et al. (16)
1 Flex-HD® Inguinal NR Inguinal 1 1 0 0
Ueno  
et al. (15)
20 Surgisis® Underlay (17) NR Ventral (18) 3 NR 0 0
Onlay (3) Inguinal (2)
Xourafas  
et al. (12)
51 AlloDerm® (4) Underlay NR Ventral NR 51 22 22
Surgisis® (1) 
Synthetic mesh (46)
Helton  
et al. (13)
53 Surgisis® IPOM (2) Sutures Ventral NR 13 17 24
Underlay (41) 
Onlay (3)
Giakoustidis 
et al. (17)
1 NR NR NR Incisional 1 0 0 0
Shah  
et al. (9)
58 AlloDerm® (29) Onlay (10) NR Ventral 9 NR 27.9 19
Permacol® and 
CollaMend® (5)
Underlay (21) 
Surgisis® and 
Strattice® (24)
Bridging (27)
Tsuda  
et al. (22)
1 Strattice® IPOM Sutures Incisional 1 Omentum 
resection
0 0
Titanium 
spiral tacks
Franklin  
et al. (5)
133 Surgisis® IPOM Tacks Inguinal (29) 32 17 5.2 0.7
Incisional (57) 
umbilical (38) 
Femoral (3) 
Parastomal (2) 
Spigelian (4)
Han et al. (6) 63 AlloDerm® IPOM Sutures Ventral (45) 63 33 15.9 1.5
Incisional (18)
Patton  
et al. (14)
67 AlloDerm® Inlay (43) Sutures Ventral 10 NR 17.9 16
Interlay (28)
Onlay (5)
Fallis et al. (18) 1 Strattice® Perineal bridge Sutures Perineal 1 1 0 NR
Gooch  
et al. (19)
1 Permacol® Hiatal Sutures Hiatal 1 0 0 NR
Pulido  
et al. (20)
1 Flex HD® Diaphragmatic Sutures Diaphragmatic 1 0 NR NR
Schiergens 
et al. (21)
1 BioA® Hiatal NR Diaphragmatic 1 0 0 0
n, number; NR, no report.
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The retrospective case–control study of Xourafas et  al. (12) 
regarding the use of meshes in incarcerated ventral hernia repair 
with a simultaneous bowel resection included five patients (out 
of 51 in the mesh group) with the implantation in underlay tech-
nique using Alloderm® in four cases and Surgisis® in one case, 
respectively. The overall infection and recurrence rate (synthetic 
and biological meshes) was 22% in a follow-up of 22  months. 
The result of an univariate and a multivariate analysis detected a 
significant risk of increased postoperative infection in the mesh 
group, without separation regarding the type of mesh.
Helton et al. (13) reported in a retrospective case–control study 
of 13 patients treated with bowel resection due to incarceration 
or strangulation in ventral hernia by the use of Surgisis Gold® in 
an open approach. The wound infection rate was 24% and the 
recurrence rate 17% in a follow-up of 14 months.
In a retrospective study of different bio-prosthetic materials 
in complex ventral hernia repair by Shah et al. (9) nine patients 
with incarceration (out of 58) were included. Different biological 
meshes were used (Alloderm®, CollaMend®, Permacol®, Surgisis®, 
and Strattice®). The overall recurrence rate was 27.9%, and surgical 
wound infections were detected in 19% in a follow-up of 1 year. 
The 17.2% of the meshes required explantation. Non-cross-linked 
porcine biologics were less likely to be explanted, but had higher 
recurrence rates compared to cross-linked porcine biologics and 
a higher infection rate compared to Alloderm® (non-cross-linked 
human dermis).
Franklin et al. published a case–control study using porcine 
small intestinal submucosa mesh (Surgisis®) for laparoscopic 
IPOM repair of hernias in infected fields in the years 2002, 2004, 
and 2008 (3–5). In summary, 133 procedures were performed 
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in 116 patients of which 17 (12.7%) required a bowel resection 
due to strangulated hernias with necrotic bowel. The overall 
recurrence rate was 5.2% and the infection rate 0.7% in a mean 
follow-up of 52 months.
Incarcerated abdominal wall hernias treated with the use 
of human dermal matrix (ADM®) in IPOM position by open 
approach in combination with vacuum wound drainage was 
reported by Han et al. (6) in a retrospective study. In 33 out of 
63 incarcerated hernias, bowel resection was performed. In a 
follow-up of 43 months, 15.9% recurrences were detected and 
1.6% suffered from a superficial wound infection. Multivariate 
analysis isolated BMI, defect size, and numbers of biological 
meshes used as risk factors to significantly affect recurrence 
rates.
Patton et al. (14) published a retrospective study of abdominal 
wall reconstructions with the use of acellular dermal matrix 
(ADM®) in complex and contaminated ventral hernias. In 51% 
of the repairs, the mesh was positioned as IPOM bridging with 
3  cm overlap, 42% as an interlay, and 8% as an onlay. The 13 
patients out of 89 were treated in case of incarcerated hernias. 
Overall, 16% developed wound infections, and in a follow-up of 
10.6 months, 17.9% suffered from a recurrent hernia.
There are some single case reports like Giakoustidis et al. (17) 
reporting of a biological mesh used in an incarcerated recurrent 
incisional hernia as well as Tsuda (22) describing a laparoscopic 
repair of an incarcerated umbilical hernia using Strattice® and 
Fallis et al. (18) publishing an open mesh repair of a strangulated 
perineal hernia after abdominoperineal resection. Another single 
case was reported by Gooch et al. (19) concerning a transthoracic 
repair of an incarcerated diaphragmatic hernia with a cross-linked 
porcine dermal collagen (Permacol®) and finally Pulido et al. (20) 
who described a laparoscopic repair in a case of chronic traumatic 
diaphragmatic hernia containing an obstructed small bowel and 
gallbladder also used Permacol®.
Schiergens et  al. (21) reported of an emergent laparoscopic 
fundoplication of acute upside-down stomach with incarceration 
using biocompatible gradually absorbable synthetic polymers 
(BioA®) in a 32-year-old male patient. The follow-up was 
uneventful.
DiSCUSSiON/SUMMARY
In summary, so far the data regarding the use of biological 
and biosynthetic meshes are very scarce and there is only one 
level 3 study published up to now. The results of this study of 
Xourafas et al. (12) comparing mesh versus mesh-free repair of 
ventral hernia with a simultaneous bowel resection obtained a 
significant risk factor for the mesh group concerning the devel-
opment of an infection. On multivariate regression analysis, 
the risk was present irrespective of drain use, defect size, and 
type of bowel resection. However, the analysis of a subgroup 
of 10 patients treated with the use of biological meshes out of 
a total of 100, which underwent mesh repair, did not reveal a 
single infection, whereas the group of polypropylene meshes 
showed a 24% infection rate. There was no reported significant 
difference in the incidence of recurrences between the mesh- 
and the mesh-free group (22 versus 24%), but unfortunately no 
comparative analysis between synthetic and biological meshes 
was published.
The results of Franklin et al. (3–5) include the highest number 
of biological mesh repairs (Surgisis®) in infected fields by lapa-
roscopic approach, which demonstrated a low ratio of required 
bowel resection (12.7%), furthermore the overall incidence 
of recurrence and infection was very low (5.2 and 0.7%) in a 
mean follow-up of 52  months. Han et  al. (6) reported, in his 
retrospective study, the highest number of treated patients due 
to incarcerated hernias with bowel resection by open approach 
using acellular dermal matrix (ADM®) with very low rate of 
infection (1.6%) as well as recurrences (15.9%) in a follow-up 
of 43  months. Both studies achieved acceptable outcome in a 
follow-up of at least 3.5 years compared to the use of synthetic 
mesh in this high-risk population (7).
In the conclusion of a critical review of biologic mesh use in 
ventral hernia repairs under contaminated conditions by Primus 
and Harris (7) as well as in the systematic review by Lee et al. (25), a 
similar statement can be found: “The available evidence is limited, 
but does not support the superiority of biologic over synthetic 
non-absorbable prosthetics in contaminated fields. Due to a lack 
of scientific evidence concerning the use of biologic mesh in case 
of laparoscopic treatment in incarcerated/strangulated ventral 
hernias (in potentially contaminated field) no recommendation 
or suggestion can be stated.”
Taking into account that there is a significantly increasing 
rate of emergent incisional hernia repair in the group of older 
men (>65 years) when analyzing the years 2001 to 2010 in the 
United States (26), the importance to treat this growing popu-
lation with an appropriate method including the selection of 
mesh type and material should be addressed in further studies 
and registries. The results of a survey of practicing surgeons 
(members of American College of Surgeons) concerning the use 
of biological meshes in abdominal reconstructions (27) revealed 
a lack of consensus in terms of indication, surgical techniques, 
as well as type of biological mesh.
Looking to the different Guidelines based on consensus 
conferences of the European Association for Endoscopic 
Surgery (EAES), International Endo Hernia Society (IEHS), 
European Hernia Society (EHS), and the World Society 
of Emergency Surgery (WSES) (28–33), we can only find a 
recommendation of the WSES in terms of the question which 
kind of mesh should be used in incarcerated/strangulated 
hernia. The WSES guideline based on a Consensus Meeting 
in 2013 (29) recommends the use of biological meshes as a 
valid option in case of emergency hernia repair in poten-
tially contaminated surgical field for patients with intestinal 
strangulation and/or concurrent bowel resection [grade 2C 
recommendation GRADE (34)]. In case of stable patients with 
strangulated obstruction and peritonitis by bowel perforation 
(contaminated-dirty surgical field), direct tissue suture is 
recommended when the hernia defect is small; in the events 
that direct tissue suture is not possible, biological mesh repair 
may be suggested (grade 2C recommendation). The choice 
between cross-linked and non-cross-linked biological mesh 
should be evaluated depending on the defect size and degree 
of contamination (grade 2C recommendation).
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Without any doubt, currently there is a very limited evidence 
for the use of biological and biosynthetic meshes in strangulated 
hernias in open as well as in laparo-endoscopic repair. Finally, there 
is an urgent need to start with randomized controlled comparative 
trials as well as to support registries with data to achieve more 
knowledge for tailored indication for the use of biological meshes.
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